Not approved by FDA. Cheap. Safe. Kills aggressive cancers. Why no Clinical Trials? Nine research papers reviewed.
Dr William Makis | 3 October 2023
Image Source: 2020 Aug – Deok-Soo Son et al
Papers and Articles Reviewed:
- 2023 Jun – Movahedi et al – Repurposing anti-parasite benzimidazole drugs as selective anti-cancer chemotherapeutics
- 2023 Apr – Chi-Son Chang et al – Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer
- 2023 Mar – Semkova et al – Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
- 2023 Mar – Haebeen Jung et al – Differential cytotoxic effects of fenbendazole on mouse lymphoma EL-4 cells and spleen cells
- 2022 Sep – Deokbae Park et al – Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
- 2022 Jan – Li-wen Ren et al – Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
- 2020 Aug – Deok-Soo Son et al – The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
- 2020 Jun – Yong Han et al – Involvement of reactive oxygen species in the anti-cancer activity of fenbendazole, a benzimidazole anthelmintic (leukemia)
- 2018 Aug – Dogra et al – Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
Source: https://makismd.substack.com/p/fenbendazole-and-cancer-at-least
Related post:
FENBENDAZOL CANCER PROTOCOL
Fenbendazol for Cancer – Clif High